Clinical Trials Browser

INDUSTRY × Solid Tumors × Appointments and Schedules × Clear all

NCT01009073 2017-11-20

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumors